These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The age-related eye disease study: the results of the clinical trial. Sackett CS; Schenning S Insight; 2002; 27(1):5-7. PubMed ID: 11962062 [TBL] [Abstract][Full Text] [Related]
7. [Antioxidants and AMD]. Edmund C Ugeskr Laeger; 2006 Oct; 168(41):3537; author reply 3537. PubMed ID: 17066533 [No Abstract] [Full Text] [Related]
8. Eye nutrient products for age-related macular degeneration: what do they contain? Arora S; Musadiq M; Mukherji S; Yang YC Eye (Lond); 2004 May; 18(5):470-3. PubMed ID: 15131676 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. West AL; Oren GA; Moroi SE Am J Ophthalmol; 2006 Jan; 141(1):157-66. PubMed ID: 16386992 [TBL] [Abstract][Full Text] [Related]
10. [The source of antioxidants]. Guggenbühl N Bull Soc Belge Ophtalmol; 2006; (301):41-5. PubMed ID: 17552431 [TBL] [Abstract][Full Text] [Related]
13. [Nutrition in prevention of age-related macular degeneration]. Szostak WB; Szostak-Wegierek D Przegl Lek; 2008; 65(6):308-11. PubMed ID: 18853663 [TBL] [Abstract][Full Text] [Related]
14. [Antioxidant micronutrients and cataract. Review and comparison of the AREDS and REACT cataract studies]. Schalch W; Chylack LT Ophthalmologe; 2003 Mar; 100(3):181-9. PubMed ID: 12640546 [TBL] [Abstract][Full Text] [Related]
15. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Moriarty-Craige SE; Adkison J; Lynn M; Gensler G; Bressler S; Jones DP; Sternberg P Am J Ophthalmol; 2005 Dec; 140(6):1020-6. PubMed ID: 16376645 [TBL] [Abstract][Full Text] [Related]
16. Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies. Hoelzl C; Bichler J; Ferk F; Simic T; Nersesyan A; Elbling L; Ehrlich V; Chakraborty A; Knasmüller S J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():49-64. PubMed ID: 16077190 [TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of treatment of age-related macular degeneration: a review. Kymes Steven M Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005 [TBL] [Abstract][Full Text] [Related]
18. [Is a cataract avoidable? Current status with special emphasis on the pathophysiology of oxidative lens damage, nutritional factors, and the ARED study]. Kottler UB; Dick HB; Augustin AJ Ophthalmologe; 2003 Mar; 100(3):190-6. PubMed ID: 12640547 [TBL] [Abstract][Full Text] [Related]